Overview

Gabapentin for Postop Pain After SSLF

Status:
Completed
Trial end date:
2020-07-25
Target enrollment:
Participant gender:
Summary
Purpose: To assess the impact of gabapentin versus placebo on overall postoperative pain and gluteal pain at 7 days after vaginal sacrospinous ligament suspension for apical pelvic organ prolapse. Participants: English-speaking women planning to undergo a vaginal SSLF. Concurrent procedures can be performed except total vaginal hysterectomy, colpocleisis, anal sphincteroplasty, fistula surgery, or urethral diverticulectomy Procedures (methods): Patients will be randomized to receive either 2 weeks of gabapentin or placebo for 2 weeks post-operatively. Standard of care pain medications will be given to both groups. Patients will be followed for 6 weeks post-operatively.
Phase:
Phase 4
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Treatments:
Gabapentin
gamma-Aminobutyric Acid